Alkundi Alamin, Momoh Rabiu
Diabetes and Endocrinology, East Kent Hospitals University NHS Foundation Trust, Kent, GBR.
Critical Care, Medway Maritime Hospital, Gillingham, GBR.
Cureus. 2024 Nov 18;16(11):e73901. doi: 10.7759/cureus.73901. eCollection 2024 Nov.
Literature evidence describing a seeming de novo occurrence of severe osteoporosis accompanied by the presence of parathyroid adenoma with normal serum parathormone level (PTH), normal serum vitamin D, and serum calcium levels is rare; hence, this case report. In the absence of raised parathormone levels and the demonstration of the presence of parathyroid adenoma, the hypothesis that the authors were left with was that could certain forms of parathyroid adenoma express factors or active substances with severe osteoclastic activity. Or, could certain expressed PTH molecules in parathyroid adenoma scenarios prove difficult to assay using conventional study methods? We have reviewed the literature in a bid to provide answers to these possible uncommon scenarios. We present the case of the above occurrence in a 65-year-old female patient with no genetic evidence of familial hypocalciuric hypercalcemia or familial hyperparathyroidism and with a normal renal function test.
关于严重骨质疏松症似乎是新发的,同时伴有甲状旁腺腺瘤,而血清甲状旁腺激素水平(PTH)正常、血清维生素D正常且血清钙水平正常的文献证据很少;因此,才有了本病例报告。在甲状旁腺激素水平未升高且证实存在甲状旁腺腺瘤的情况下,作者剩下的假设是,某些形式的甲状旁腺腺瘤是否会表达具有严重破骨细胞活性的因子或活性物质。或者,在甲状旁腺腺瘤情况下某些表达的PTH分子是否难以用传统研究方法进行检测?我们查阅了文献,试图为这些可能不常见的情况提供答案。我们报告了一名65岁女性患者出现上述情况的病例,该患者没有家族性低钙血症性高钙血症或家族性甲状旁腺功能亢进的遗传证据,且肾功能检查正常。